Addition of oral thalidomide to standard antitubercular regimen for initial 2 months improves the outcome in patients of tubercular meningitis as compared to standard therapy alone.
Not Applicable
- Conditions
- Health Condition 1: A170- Tuberculous meningitis
- Registration Number
- CTRI/2020/08/027438
- Lead Sponsor
- AIIMS Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically diagnosed new cases of tuberculous meningitis using clinical, CSF and radiological finding.
2.Within one month of starting anti tubercular treatment.
3.Willing to participate in study by signing informed consent.
4. Age 18 year or older of both sexes.
Exclusion Criteria
1.Confirmed meningitis other than TB
2.Pregnancy.
3.Pre-existing neuropathy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method